← Open Payments lookup

KENT MCDANIEL: Open Payments

NPI 1871640789 · GLEN ALLEN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$398,591 in 390 payments from 6 companies in 2025. Trend: 2023 $410,179 · 2024 $404,509 · 2025 $398,591

Speaker / faculty: $349,752Travel & lodging: $27,784Consulting: $14,200Food & beverage: $6,855
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.92$98,215
Janssen Pharmaceuticals, Inc95$84,375
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)80$79,299
Teva Pharmaceuticals USA, Inc.51$59,434
Neurocrine BioSciences, Inc.47$59,044
E.R. Squibb & Sons, L.L.C.25$18,223

Products named: INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA, INGREZZA, UZEDY, AUSTEDO XR, REXULTI, COBENFY.

Industry payments across VA — which companies pay providers there.